pet-30a (Merck KGaA)
90
Structured Review
Merck KGaA
pet-30a
Pet 30a, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pet-30a/pet32a/10__1007_slash_s13206___025___00210___5-54-6-12
Average 90 stars, based on 1 article reviews
Pet 30a, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pet-30a/pet32a/10__1007_slash_s13206___025___00210___5-54-6-12
Average 90 stars, based on 1 article reviews
pet-30a - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Fab2-SARAH: An Escherichia coli-Based Antibody Fragment Platform for Scalable, Cost-Effective In Vitro Diagnostics Article Snippet: The latest global pandemic and the ongoing threat of emerging pathogens have highlighted the need for effective diagnostic strategies for infectious diseases.. Current methods primarily depend on immunoassays, such as enzyme-linked immunosorbent assays and rapid diagnostic tests, which utilize antibodies to detect specific analytes.. However, traditional mammalian cell systems for antibody production are expensive and carry a risk of viral contamination. Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects. Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( Modification:Article Title: Fab2-SARAH: An Escherichia coli-Based Antibody Fragment Platform for Scalable, Cost-Effective In Vitro Diagnostics Article Snippet: The latest global pandemic and the ongoing threat of emerging pathogens have highlighted the need for effective diagnostic strategies for infectious diseases.. Current methods primarily depend on immunoassays, such as enzyme-linked immunosorbent assays and rapid diagnostic tests, which utilize antibodies to detect specific analytes.. However, traditional mammalian cell systems for antibody production are expensive and carry a risk of viral contamination. Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects. Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( Plasmid Preparation:Article Title: Fab2-SARAH: An Escherichia coli-Based Antibody Fragment Platform for Scalable, Cost-Effective In Vitro Diagnostics Article Snippet: The latest global pandemic and the ongoing threat of emerging pathogens have highlighted the need for effective diagnostic strategies for infectious diseases.. Current methods primarily depend on immunoassays, such as enzyme-linked immunosorbent assays and rapid diagnostic tests, which utilize antibodies to detect specific analytes.. However, traditional mammalian cell systems for antibody production are expensive and carry a risk of viral contamination. Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects. Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( Article Title: Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects Article Snippet: The PCR products were digested and inserted into slightly modified pET-28a(+) or pET-30a( |